减重和肥胖管理市场按治疗类型、给药途径、年龄层、最终用户和地区划分

减重和肥胖管理市场规模预计在 2025 年达到 1,651 亿美元，预计到 2032 年将达到 2,950.9 亿美元，2025 年至 2032 年的复合年增长率为 8.7%。

全球减重和肥胖管理市场是一个快速扩张的医疗保健领域，其驱动力源于不断上升的肥胖率、日益增强的健康意识以及全球对肥胖相关併发症日益增长的认识。该市场涵盖了全面的产品和服务，包括营养补充剂、代餐、健身器材、体重管理设备、药物干预以及促进减肥和保持健康体重的外科手术。

糖尿病、心血管疾病和METABOLIC INC.症候群等文明病的日益流行，极大地推动了市场的成长轨迹，从而对有效的体重管理解决方案产生了迫切的需求。其他优点包括技术进步，例如非侵入性治疗方案、数位健康平台以及迎合不同消费者偏好和医疗需求的个人化营养方法。该行业透过从医院和诊所到零售药局和线上平台等多种分销管道，服务于包括成人、青少年和儿童在内的各类人群。政府倡导健康生活方式的倡议、不断增长的医疗保健支出，以及人们越来越接受体重管理是一种医疗必需品而非美容偏好，这些都进一步推动了市场的扩张，使其成为全球医疗保健生态系统的重要组成部分。

市场动态

全球减重和肥胖管理市场的主要驱动力是全球肥胖率的惊人成长。根据世界卫生组织 (WHO) 的报告，自 1975 年以来，肥胖人数增加了两倍，这使得所有年龄层的人对有效的体重管理解决方案的需求都很大。人们对肥胖相关健康併发症（例如 2 型糖尿病、心血管疾病、睡眠呼吸中止症和某些癌症）的认识不断提高，迫使人们寻求专业的体重管理干预措施，从而扩大了市场的消费群。微创手术的技术创新、先进药物製剂的开发以及包括行动应用程式和穿戴式装置在内的数位健康技术的整合，显着提高了治疗效果和患者依从性，推动了市场成长。然而，该市场也面临重大限制因素，包括与外科手术相关的高成本和昂贵的体重管理计划，这限制了低收入群体获得这些服务的机会，并阻碍了其广泛应用。减重药物和医疗设备的严格法律规范，加上某些干预措施可能产生的副作用和安全问题，为市场扩张带来了额外的挑战。在某些地区，围绕肥胖和体重管理治疗的文化污名也阻碍了市场渗透。儘管存在这些挑战，但在可支配收入不断增长、都市化和饮食习惯不断变化、新客户群不断涌现的市场中，仍存在着巨大的机会。预防性医疗保健的日益流行、远端医疗日益普及，以及根据个人基因图谱和生活方式因素量身定制的个人化营养和健身计划的开发，对于寻求利用不断变化的消费趋势和医疗保健服务模式的开发商来说，代表着巨大的成长潜力。

本次调查的主要特点

• 本报告对全球减重和肥胖管理市场进行了详细分析，提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），以 2024 年为基准年。
• 它揭示了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数，对全球减重和肥胖管理市场的主要企业进行了概述。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、最新策略、市场扩张和行销策略做出明智的决策。
• 本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过全球减肥和肥胖管理市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章：调查目标和先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 抑制因素
• 机会
• 影响分析
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 2020-2032 年全球减重及肥胖管理市场（依治疗类型）

• 介绍
• 微创/非手术治疗

5. 全球减重及肥胖管理市场（依给药途径划分），2020 年至 2032 年

• 介绍
• 口服
• 肠外
• 其他（经皮）

6. 2020-2032 年全球减重及肥胖管理市场（依性别）

• 介绍
• 男性
• 女士

7. 2020-2032 年全球减重及肥胖管理市场（依年龄层划分）

• 介绍
• 成人
• 老年人
• 孩子们

8. 全球减重和肥胖管理市场（按最终用户划分），2020 年至 2032 年

• 介绍
• 医院和诊所
• 门诊手术中心（ASC）
• 居家照护
• 减重中心或健身中心
• 其他的

9. 2020-2032 年全球减重及肥胖管理市场（按地区）

• 介绍
• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十章 竞争格局

• Novo Nordisk
• GlaxoSmithKline
• AstraZeneca
• Pfizer
• Merck & Co.
• Sanofi
• Amgen
• Eli Lilly and Company
• Johnson & Johnson
• Herbalife Nutrition Ltd
• GNC Holdings
• Amway
• Nestle Health Science
• Iovate Health Sciences
• Weight Watchers（WW International）
• SlimFast（Glanbia Performance Nutrition）
• Life Extension
• NutraScience Labs
• Other Players

第 11 章分析师建议

• 机会
• 一致的机会地图

第十二章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Weight Loss And Obesity Management Market is estimated to be valued at USD 165.10 Bn in 2025 and is expected to reach USD 295.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

The global weight loss and obesity management market represents a rapidly expanding healthcare sector driven by escalating obesity rates, increasing health consciousness, and growing awareness of obesity-related comorbidities worldwide. This market encompasses a comprehensive range of products and services including dietary supplements, meal replacements, fitness equipment, weight management devices, pharmaceutical interventions, and surgical procedures designed to facilitate weight reduction and maintain healthy body weight.

The market's growth trajectory is significantly influenced by rising prevalence of lifestyle-related diseases such as diabetes, cardiovascular disorders, and metabolic syndrome, which have created urgent demand for effective weight management solutions. Additionally, the market benefits from technological advancements in non-invasive treatment options, digital health platforms, and personalized nutrition approaches that cater to diverse consumer preferences and medical requirements. The industry serves various demographics including adults, adolescents, and pediatric populations through multiple distribution channels ranging from hospitals and clinics to retail pharmacies and online platforms. Government initiatives promoting healthy lifestyles, increasing healthcare expenditure, and growing acceptance of weight management as a medical necessity rather than cosmetic preference further propel market expansion, making it a critical component of the global healthcare ecosystem.

Market Dynamics

The global weight loss and obesity management market is primarily driven by the alarming increase in obesity rates globally, with the World Health Organization reporting that obesity has tripled since 1975, creating substantial demand for effective weight management solutions across all age groups. Rising awareness about obesity-related health complications including type 2 diabetes, cardiovascular diseases, sleep apnea, and certain cancers is compelling individuals to seek professional weight management interventions, thereby expanding the market's consumer base. Technological innovations in minimally invasive surgical procedures, development of advanced pharmaceutical formulations, and integration of digital health technologies including mobile applications and wearable devices are significantly enhancing treatment efficacy and patient compliance, driving market growth. However, the market faces considerable restraints including high costs associated with surgical interventions and premium weight management programs, which limit accessibility for lower-income populations and create barriers to widespread adoption. Stringent regulatory frameworks governing weight loss medications and medical devices, coupled with potential side effects and safety concerns associated with certain interventions, pose additional challenges to market expansion. Cultural stigma surrounding obesity and weight management treatments in certain regions also impedes market penetration. Despite these challenges, the market presents substantial opportunities through emerging economies where rising disposable incomes, urbanization, and changing dietary patterns are creating new customer segments. The growing trend toward preventive healthcare, increasing acceptance of telemedicine, and development of personalized nutrition and fitness programs tailored to individual genetic profiles and lifestyle factors offer significant growth potential for market players seeking to capitalize on evolving consumer preferences and healthcare delivery models.

Key Features of the Study

• This report provides in-depth analysis of the global weight loss and obesity management market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global weight loss and obesity management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novo Nordisk, GlaxoSmithKline, AstraZeneca, Pfizer, Merck & Co., Sanofi, Amgen, Eli Lilly and Company, Johnson & Johnson, Herbalife Nutrition Ltd, GNC Holdings, Amway, Nestle Health Science, Iovate Health Sciences, Weight Watchers (WW International), SlimFast (Glanbia Performance Nutrition), Life Extension, and NutraScience Labs.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global weight loss and obesity management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global weight loss and obesity management market

Market Segmentation

• Type of Treatment Insights (Revenue, USD Bn, 2020 - 2032)
  • Drugs
  • Prescription Drugs
  • Over-the-Counter (OTC) Drugs
  • Dietary Supplements
  • Nutraceuticals
  • Herbal or Botanical Supplements
  • Protein and Fiber Supplements
  • Vitamin or Mineral Formulations (Weight-Loss Focused)
  • Appetite suppressants
  • Others (Metabolism enhancers, etc.)
  • Surgery Therapies
  • Bariatric Surgeries
  • Sleeve Gastrectomy
  • Biliopancreatic Diversion (BPD)
  • Others (Duodenal Switch, etc.)
  • Minimally Invasive or Non-Surgical Procedures
  • Intragastric Balloon Systems
  • Others (Endoscopic Sleeve Gastroplasty, etc.)
• Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
  • Oral
  • Parenteral
  • Others (Transdermal)
• Gender Insights (Revenue, USD Bn, 2020 - 2032)
  • Male
  • Female
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Adult
  • Geriatric
  • Pediatric
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Homecare Settings
  • Obesity Treatment Centers or Fitness Centers
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Novo Nordisk
  • GlaxoSmithKline
  • AstraZeneca
  • Pfizer
  • Merck & Co.
  • Sanofi
  • Amgen
  • Eli Lilly and Company
  • Johnson & Johnson
  • Herbalife Nutrition Ltd
  • GNC Holdings
  • Amway
  • Nestle Health Science
  • Iovate Health Sciences
  • Weight Watchers (WW International)
  • SlimFast (Glanbia Performance Nutrition)
  • Life Extension
  • NutraScience Labs
  • Other Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Weight Loss and Obesity Management Market, By Type of Treatment
  • Global Weight Loss and Obesity Management Market, By Route of Administration
  • Global Weight Loss and Obesity Management Market, By Gender
  • Global Weight Loss and Obesity Management Market, By Age Group
  • Global Weight Loss and Obesity Management Market, By End User
  • Global Weight Loss and Obesity Management Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Weight Loss and Obesity Management Market, By Type of Treatment, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
    • Drugs
      • Prescription Drugs
      • Over-the-Counter (OTC) Drugs
    • Dietary Supplements
      • Nutraceuticals
      • Herbal or Botanical Supplements
      • Protein and Fiber Supplements
      • Vitamin or Mineral Formulations (Weight-Loss Focused)
      • Appetite suppressants
      • Others (Metabolism enhancers, etc.)
    • Surgery Therapies
      • Bariatric Surgeries
    • Sleeve Gastrectomy
    • Biliopancreatic Diversion (BPD)
    • Others (Duodenal Switch, etc.)
• Minimally Invasive or Non-Surgical Procedures
  • Intragastric Balloon Systems
  • Others (Endoscopic Sleeve Gastroplasty, etc.)

5. Global Weight Loss and Obesity Management Market, By Route of Administration, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Transdermal)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Weight Loss and Obesity Management Market, By Gender, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Weight Loss and Obesity Management Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Weight Loss and Obesity Management Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers (ASCs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Homecare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Obesity Treatment Centers or Fitness Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Weight Loss and Obesity Management Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Novo Nordisk
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amgen
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Herbalife Nutrition Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GNC Holdings
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amway
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nestle Health Science
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Iovate Health Sciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Weight Watchers (WW International)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SlimFast (Glanbia Performance Nutrition)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Life Extension
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• NutraScience Labs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Other Players
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us